, a bio/informatics shared resource is still "open for business" - Visit the CDS website

Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.

Josephy PD, Evans DH, Parikh A, Guengerich FP
Chem Res Toxicol. 1998 11 (1): 70-4

PMID: 9477228 · DOI:10.1021/tx970171q

We describe the construction of a new strain of Escherichia coli designed to bioactivate aromatic amines and to detect their mutagenicity with high sensitivity. Strain DJ4309 bears two plasmids, a pACYC184-derived plasmid which expresses Salmonella typhimurium acetyl CoA:arylamine N-acetyltransferase (NAT) and a pBR322-derived plasmid which expresses human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase. The combined actions of these enzymes convert aromatic amines into reactive, mutagenic N-acetoxy esters. The strain also carries a mutated copy of the lacZ gene (on an F' factor) which reverts to the wild-type gene by a -(GpC) frameshift mutation. Strain DJ4309 expresses high levels of NAT and cytochrome P450 1A2 and is very sensitive to mutagenesis induced by representative aromatic amines. Mutagenicity of 2-aminoanthracene in strain DJ4309 is higher than can be obtained by rat liver homogenate 9000g supernatant (S9) activation in the parent strain lacking the P450 expression vector. Strain DJ4309 provides a useful system for detecting mutagenic aromatic amines and for studying their metabolism by human P450 1A2.

MeSH Terms (10)

Arylamine N-Acetyltransferase Biotransformation Cytochrome P-450 CYP1A2 Escherichia coli Humans Hydrocarbons, Aromatic Mutagens NADH, NADPH Oxidoreductases NADPH-Ferrihemoprotein Reductase Plasmids

Connections (1)

This publication is referenced by other Labnodes entities: